Cargando…
The lysosomotropic drug LeuLeu-OMe induces lysosome disruption and autophagy-independent cell death in Trypanosoma brucei
Background: Trypanosoma brucei is a blood-borne, protozoan parasite that causes African sleeping sickness in humans and nagana in animals. The current chemotherapy relies on only a handful of drugs that display undesirable toxicity, poor efficacy and drug-resistance. In this study, we explored the u...
Autores principales: | Koh, Hazel X., Aye, Htay M., Tan, Kevin S. W., He, Cynthia Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349101/ https://www.ncbi.nlm.nih.gov/pubmed/28357304 http://dx.doi.org/10.15698/mic2015.08.217 |
Ejemplares similares
-
Effect of the Hydration Shell on the Carbonyl Vibration in the Ala-Leu-Ala-Leu Peptide
por: Hassan, Irtaza, et al.
Publicado: (2021) -
Future U.S. supply of Mo-99 production through fission based LEU/LEU technology
por: Welsh, James, et al.
Publicado: (2015) -
Subverting lysosomal function in Trypanosoma brucei
por: Alsford, Sam
Publicado: (2015) -
LeuRS can leucylate type I and type II tRNA(Leu)s in Streptomyces coelicolor
por: Fan, Jia-Yi, et al.
Publicado: (2019) -
The Environment Shapes the Inner Vestibule of LeuT
por: Sohail, Azmat, et al.
Publicado: (2016)